How Japan is creating new opportunities in the field of regenerative medicine
from Harvard Business Review
As biotech companies race toward the opportunities in Japan, no life sciences sector has received more attention, government support, and regulatory reform than the important field of regenerative medicine. Regeneratives are pharmaceutical cell therapy products that replace or restore cells and tissues lost to disease or aging. Some regenerative medicines stimulate our bodies to regrow or repair, so the field can include the use of stem cells for tissue engineering.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063